121 related articles for article (PubMed ID: 38860943)
21. Haploinsufficiency of the TDP43 ubiquitin E3 ligase RNF220 leads to ALS-like motor neuron defects in the mouse.
Ma P; Li Y; Wang H; Mao B
J Mol Cell Biol; 2021 Aug; 13(5):374-382. PubMed ID: 33386850
[TBL] [Abstract][Full Text] [Related]
22. Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.
Weskamp K; Tank EM; Miguez R; McBride JP; Gómez NB; White M; Lin Z; Gonzalez CM; Serio A; Sreedharan J; Barmada SJ
J Clin Invest; 2020 Mar; 130(3):1139-1155. PubMed ID: 31714900
[TBL] [Abstract][Full Text] [Related]
23. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.
Korhonen P; Pollari E; Kanninen KM; Savchenko E; Lehtonen Š; Wojciechowski S; Pomeshchik Y; Van Den Bosch L; Goldsteins G; Koistinaho J; Malm T
IBRO Rep; 2019 Jun; 6():74-86. PubMed ID: 30705990
[TBL] [Abstract][Full Text] [Related]
24. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
25. Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1
Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
Eur J Neurosci; 2017 Aug; 46(4):2001-2014. PubMed ID: 28715117
[TBL] [Abstract][Full Text] [Related]
26. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.
Hatzipetros T; Bogdanik LP; Tassinari VR; Kidd JD; Moreno AJ; Davis C; Osborne M; Austin A; Vieira FG; Lutz C; Perrin S
Brain Res; 2014 Oct; 1584():59-72. PubMed ID: 24141148
[TBL] [Abstract][Full Text] [Related]
27. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
28. The Influence of Bifidobacterium bifidum and Bacteroides fragilis on Enteric Glial Cell-Derived Neurotrophic Factors and Inflammasome.
Yang PC; Li XJ; Yang YH; Qian W; Li SY; Yan CH; Wang J; Wang Q; Hou XH; Dai CB
Inflammation; 2020 Dec; 43(6):2166-2177. PubMed ID: 32638263
[TBL] [Abstract][Full Text] [Related]
29. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
30. C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis.
Valente T; Mancera P; Tusell JM; Serratosa J; Saura J
Neurobiol Aging; 2012 Sep; 33(9):2186-99. PubMed ID: 22015310
[TBL] [Abstract][Full Text] [Related]
31. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity.
Kitamura A; Nakayama Y; Shibasaki A; Taki A; Yuno S; Takeda K; Yahara M; Tanabe N; Kinjo M
Sci Rep; 2016 Jan; 6():19230. PubMed ID: 26757674
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis.
Watanabe-Matsumoto S; Moriwaki Y; Okuda T; Ohara S; Yamanaka K; Abe Y; Yasui M; Misawa H
Neurosci Res; 2018 Aug; 133():48-57. PubMed ID: 29154923
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice.
McLeod VM; Chiam MDF; Lau CL; Rupasinghe TW; Boon WC; Turner BJ
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32621747
[TBL] [Abstract][Full Text] [Related]
34. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
[TBL] [Abstract][Full Text] [Related]
35. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
Mitchell JC; Constable R; So E; Vance C; Scotter E; Glover L; Hortobagyi T; Arnold ES; Ling SC; McAlonis M; Da Cruz S; Polymenidou M; Tessarolo L; Cleveland DW; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():36. PubMed ID: 26108367
[TBL] [Abstract][Full Text] [Related]
36. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
37. TDP43 interacts with MLH1 and MSH6 proteins in a DNA damage-inducible manner.
Provasek VE; Kodavati M; Kim B; Mitra J; Hegde ML
Mol Brain; 2024 Jun; 17(1):32. PubMed ID: 38840222
[TBL] [Abstract][Full Text] [Related]
38. Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS.
Rabinovich-Nikitin I; Ezra A; Barbiro B; Rabinovich-Toidman P; Solomon B
J Neuroinflammation; 2016 May; 13(1):123. PubMed ID: 27230771
[TBL] [Abstract][Full Text] [Related]
39. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
40. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
